Stepan Company
General ticker "SCL" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $1.2B (TTM average)
Stepan Company follows the US Stock Market performance with the rate: 45.4%.
Estimated limits based on current volatility of 1.2%: low 61.34$, high 62.79$
Factors to consider:
- Earnings expected soon, date: 2026-10-28 bmo
- Company pays dividends (quarterly): last record date 2026-09-01, amount 0.40$ (Y2.58%)
- Total employees count: 2328 (-2.8%) as of 2025
- US accounted for 55.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Manufacturing issues, Raw material costs, Regulatory and compliance, Market competition, Supply chain disruptions
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [36.25$, 56.89$]
- 2026-12-31 to 2027-12-31 estimated range: [40.36$, 61.67$]
Financial Metrics affecting the SCL estimates:
- Positive: with PPE of 25.9 at the end of fiscal year the price was neutral
- Positive: 11.37 < Operating cash flow per share per price, % of 13.71
- Positive: 0.56 < Operating profit margin, % of 3.35
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 1.95
- Positive: 0.59 < Industry operating profit margin (median), % of 1.52
- Positive: Inventory ratio change, % of -0.40 <= -0.37
- Positive: 2.08 < Industry earnings per price (median), % of 2.85
- Negative: 49.86 < Shareholder equity ratio, % of 52.76 <= 58.56
- Positive: Interest expense per share per price, % of 2.05 <= 2.54
Short-term SCL quotes
Long-term SCL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,325.77MM | $2,180.27MM | $2,348.01MM |
| Operating Expenses | $2,267.16MM | $2,109.79MM | $2,269.46MM |
| Operating Income | $58.61MM | $70.48MM | $78.55MM |
| Non-Operating Income | $-10.22MM | $-10.04MM | $-18.64MM |
| Interest Expense | $12.10MM | $14.18MM | $22.11MM |
| R&D Expense | $59.04MM | $55.67MM | $59.28MM |
| Income(Loss) | $48.39MM | $60.44MM | $59.90MM |
| Taxes | $8.19MM | $10.07MM | $13.01MM |
| Net Income(Loss)* | $40.20MM | $50.37MM | $46.90MM |
| Stockholders Equity | $1,216.49MM | $1,169.93MM | $1,244.01MM |
| Inventory | $265.56MM | $288.72MM | $298.83MM |
| Assets | $2,363.35MM | $2,304.65MM | $2,357.70MM |
| Operating Cash Flow | $174.88MM | $162.05MM | $147.88MM |
| Capital expenditure | $260.33MM | $122.78MM | $122.51MM |
| Investing Cash Flow | $-258.67MM | $-116.94MM | $-89.05MM |
| Financing Cash Flow | $33.28MM | $-64.52MM | $-35.44MM |
| Earnings Per Share** | $1.77 | $2.20 | $2.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.